Status:
NOT_YET_RECRUITING
Patterns of Relapse After Neoadjuvant Chemotherapy in Breast Cancer
Lead Sponsor:
Assiut University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18-100 years
Brief Summary
This study aims to identify patterns of relapse after Neoadjuvant Chemotherapy (NAC) for breast cancer to refine follow up recommendations.
Detailed Description
Neoadjuvant chemotherapy (NAC) is usually used to facilitate breast-conserving surgery and improve surgical outcomes for breast cancer patients \[1\]. In addition, NAC can help to eradicate micrometas...
Eligibility Criteria
Inclusion
- Female patients aged \>= 18
- Pathologically proved breast cancer
- PS 0-1 (ECOG)
- Patients indicated to receive NAC
Exclusion
- Patients with metastatic disease at diagnosis
- Patients who did not undergo subsequent curative intent surgery
- Those who received Neoadjuvant hormonal treatment
- Those that had incomplete treatment information
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06210347
Start Date
January 1 2024
End Date
January 1 2026
Last Update
January 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.